Asia-Pacific Biochips Market - Size
Base Year For Estimation
2024
Forecast Data Period
2025-2030
Historical Data Period
2018-2023
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
Biochips are small laboratories which perform hundreds and thousands of biochemical reactions and decoding the genes in less time. Biochips are mostly used in the study of molecular biology. Biochips also known as biological microarray chips have transformed the healthcare industry to an extraordinary level and its applications have solved various health issues.
Asia Pacific Biochips Market Segments Size & Growth:
Asia Pacific BiochipMarket is accounted for $ 2 billion in 2017 and expected to grow at a CAGR of 25.2% to reach $7.9 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by rising in the usage of personalised medicine, rapid diagnosis, and investments from the government. However, high cost and lack of awareness related to biological microarray hinder the growth of the Asia Pacific Biochipmarket.
Asia Pacific Biochips Market Segments Share:
Asia Pacific Biochip Market is categorised into by product type which consists of tissues biochip,
Asia-Pacific Biochips Market - Growth
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
protein microarrays, DNA microarrays, carbohydrate biochips, and lab-on-chip. DNA microarrays have the most significant share because of increase in demand in the fields of proteomics and genomics. By application, Asia Pacific Biochip market is segmented as drug discovery, proteomics, cancer research, gene sequencing, and gene expression. Among all drug discovery and gene expression are expected to have high growth rate during the forecast period 2018-2024, due to increase in demand for personalised medicine and genetic disorders.
By Geography, China is dominating the Asia Pacific biochip market, and the growth in the Asia Pacific is mainly attributed because of the increasing adoption of precision medicine and demand for rapid diagnostics.Furthermore, India is witnessing the fastest growth during the forecast period, due to rising patients, healthcare awareness and government funding.
Asia Pacific Biochip Market Segments Trends:
- In recent research done at IIT Hyderabad has developed a new device that
You can also purchase parts of this report. Do you want to check out a section wise price list
Asia-Pacific Biochips Market - Porter's Five Force Analysis
Source: Envision Intelligence Analysis & Experts Insights.
*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
can detect infectious malaria diseases at a little cost and accuracy in November 2017.
In January 2017, Abbott Laboratories acquired St.Jude Medical Inc. to expand opportunities for diagnostics and pharmaceuticals.
Asia Pacific Biochip Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Cepheid Inc.
- Cellix
- Biomerieux SA
- Beckman Coulter Inc.
- FLUIDIGM CORPORATION
Exclusive Benefits
Credibility and
Transparency
We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.
Exhaustive
Coverage
Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.
Competitive
Edge
Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.
Golden
pportunities
Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.
Top-notch Reportsd
Guaranteed
Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.
Post Purchase
Support
Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.
